Nitroglycerin Orifarm (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Nitroglycerin Orifarm, is a nitrate vasodilator presented as a sublingual formulation for sublingual use. It treats acute angina pectoris and is used for prophylaxis of angina in adults.

GNH USA supplies Nitroglycerin Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitroglycerin Orifarm acts on the coronary and peripheral vascular system to relieve and prevent angina episodes. - Acute angina pectoris: provides rapid relief of chest pain during an attack. - Prophylaxis of angina: reduces the frequency of angina episodes when taken before exertion. - Chronic stable angina: helps control symptoms during daily activities and exercise.

Nitroglycerin Orifarm may cause a range of adverse reactions.

Common Side Effects: - Headache: throbbing pain often described as a pressure sensation. - Flushing: warmth and redness of the face or neck. - Dizziness or light‑headedness: due to reduced blood pressure. - Hypotension: mild drop in systolic blood pressure. - Tachycardia: compensatory increase in heart rate. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to fainting. - Syncope: sudden loss of consciousness. - Myocardial infarction: rare but possible in vulnerable patients. - Allergic reaction: rash, itching, or swelling. - Methemoglobinemia: rare blood disorder causing reduced oxygen delivery.

Before prescribing Nitroglycerin Orifarm, clinicians should consider several safety factors. - Cardiovascular assessment: evaluate blood pressure and heart rate. - Concomitant nitrates: avoid use with other nitrate preparations. - Phosphodiesterase‑5 inhibitors: do not combine with sildenafil, tadalafil, or similar agents. - Anemia or hypovolemia: use with caution in patients with low blood volume. - Abrupt discontinuation: taper to prevent rebound angina. - Store at room temperature: keep in the original container, protect from moisture and light.

Nitroglycerin Orifarm can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): risk of profound hypotension. - Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect. - Riociguat: synergistic vasodilation leading to severe blood pressure fall.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors, beta‑blockers): may enhance blood pressure lowering. - Diuretics: increased risk of volume depletion and hypotension. - Alcohol: can potentiate vasodilatory effects. - Antidiabetic agents: monitor for altered glucose control due to hemodynamic changes.